Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EPHA5 antisense RNA 1 (EPHA5-AS1) is a long non-coding RNA transcribed antisense to the EPHA5 protein-coding gene. As with other antisense lncRNAs, EPHA5-AS1 is thought to regulate the expression of its corresponding sense gene (EPHA5), potentially by mechanisms such as transcriptional interference, modulation of chromatin structure, or stabilization/destabilization of EPHA5 mRNA. The exact biological and pathological functions of EPHA5-AS1 remain unclear, and it is not a direct therapeutic target such as a receptor or enzyme, but rather acts as a regulatory RNA. No evidence was found for its direct targeting by drugs, nor for its use as a clinical biomarker or association with specific safety concerns.
Regulation of the expression of the EPHA5 gene, likely by antisense RNA interference mechanisms; antisense lncRNAs can regulate sense mRNA levels by forming RNA-RNA duplexes, transcriptional interference, or chromatin remodeling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EPHA5 antisense RNA 1 (EPHA5-AS1).